Venous Thromboembolism: all 708 studies
Page 6 of 8. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active CancerCompletedNCT02742623
- Tumor-educated Platelets in Venous ThromboembolismCompletedNCT02739867
- Detecting Circulating Emboli in Patients with Acute Venous ThromboembolismWithdrawnNCT02735759Not applicable
- IgG Dependent Monocyte Activation in Proximal Venous ThromboembolismCompletedNCT02713581
- Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill PatientsWithdrawnNCT02707263Not applicable
- Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin DoseCompletedNCT02704052Early Phase 1
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery PatientsCompletedNCT02687204Phase 1
- StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot StudyStatus unknownNCT02679664Phase 2
- Venous Thromboembolism in Renally Impaired Patients and Direct Oral AnticoagulantsTerminatedNCT02664155Phase 3
- Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)CompletedNCT02661568
- Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer PatientsTerminatedNCT02583191Phase 3
- Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)CompletedNCT02558465
- The Clinical Application of Infrared Thermal Imaging Detecting Venous ThromboembolismCompletedNCT02552420
- Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMSCompletedNCT02546817
- Tumescent Antibiotic Delivery for Prevention of Surgical Site InfectionStatus unknownNCT02503904Phase 2/3
- Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH DoseStatus unknownNCT02486666Phase 3
- Venous Thromboembolic Complications in Ovarian CancerStatus unknownNCT02480790
- : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft SurgeryCompletedNCT02474212Phase 4
- Haemorrhages and Thromboembolic Venous Disease of the PostpartumCompletedNCT02443610
- Rivaroxaban in Bariatric SurgeryCompletedNCT02438098Phase 1
- Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter SystemWithdrawnNCT02420626
- Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous ThromboembolismStatus unknownNCT02411097Not applicable
- Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With CancerCompletedNCT02407717
- The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - StudyCompletedNCT02379806Phase 3
- Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic SurgeryCompletedNCT02334007Phase 1/2
- Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee ArthroplastyCompletedNCT02271399Phase 2
- Long Term Outcomes of Venous ThromboembolismStatus unknownNCT02268630
- Follow-up in Rivaroxaban Patients in Setting of ThromboembolismCompletedNCT02248610
- A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill PatientsCompletedNCT02213978
- Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT02210819
- Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral AnticoagulantsCompletedNCT02185027
- Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement SurgeryCompletedNCT02170935Phase 2
- BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement SurgeryCompletedNCT02170701Phase 2
- Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study)Status unknownNCT02160964
- Global Anticoagulant Registry in the FIELD- Venous Thromboembolic EventsCompletedNCT02155491
- Pharmacokinetics of Enoxaparin in Intensive Care PatientsCompletedNCT02095509Phase 4
- Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific AnticoagulantCompletedNCT02079584
- Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary EvaluationTerminatedNCT02066597Phase 2
- Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDsCompletedNCT02066454Phase 3
- Apixaban for the Prevention of Venous Thromboembolism in Cancer PatientsCompletedNCT02048865Phase 2
- Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous ThromboembolismStatus unknownNCT02017743
- Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With CancerCompletedNCT01989845Phase 4
- Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee ArthroplastyCompletedNCT01984190
- Prophylaxis of Venous Thromboembolism in Advanced Lung CancerStatus unknownNCT01980849Phase 3
- Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction ModelCompletedNCT01972243
- Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.CompletedNCT01958203
- A Comparative Study of Prophylactic Anticoagulation in Meningioma SurgeryCompletedNCT01941602
- Weight Based Enoxaparin in Trauma PatientsStatus unknownNCT01916707Phase 4
- Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma PatientsWithdrawnNCT01890044
- Eliquis Regulatory Post Marketing Surveillance (rPMS)CompletedNCT01885585
- PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous ThromboembolismCompletedNCT01855698
- Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University HospitalCompletedNCT01851239
- Feasibility Study of Geko vs. IPCs in TraumaCompletedNCT01835990Phase 2
- Anticoagulation Length in Cancer Associated ThrombosisTerminatedNCT01817257Phase 2
- Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study ProgrammeCompletedNCT01809015
- Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With CancerCompletedNCT01803022
- Study on the Clinical Course Of Pulmonary EmbolismCompletedNCT01781858
- Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of AgeWithdrawnNCT01773174Phase 2
- Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill PatientsCompletedNCT01744431
- Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee ArthroplastyCompletedNCT01720108Phase 3
- Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee ArthroplastyCompletedNCT01713361Phase 2
- Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT01619007
- Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer ResectionTerminatedNCT01608919Not applicable
- Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismCompletedNCT01602445
- Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer PatientsWithdrawnNCT01602432
- Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlertsCompletedNCT01598805Not applicable
- Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal CancerStatus unknownNCT01567917
- Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through PathwaysCompletedNCT01561885Not applicable
- Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous ThromboembolismCompletedNCT01559207
- Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)CompletedNCT01524653Phase 2
- Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro FertilizationCompletedNCT01524393
- Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)WithdrawnNCT01523418
- Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture SurgeryStatus unknownNCT01509118
- ICU Venous Thromboembolism Incidence Study in a Chinese PopulationStatus unknownNCT01504087
- Optimal Prophylactic Method of Venous Thromboembolism (VTE)Status unknownNCT01448746Phase 3
- Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical PatientsWithdrawnNCT01446510
- Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty SurgeryCompletedNCT01431456Phase 3
- Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)CompletedNCT01428544
- Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism TreatmentCompletedNCT01428531
- Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical PatientsCompletedNCT01401725Not applicable
- Institutional Registry of Thromboembolic DiseaseStatus unknownNCT01372514
- National Inferior Vena Cava (IVC) Filter RegistryTerminatedNCT01367184
- Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese PatientsStatus unknownNCT01363193Not applicable
- National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer PatientsCompletedNCT01362933
- Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)Status unknownNCT01357941
- Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K AntagonistCompletedNCT01348074Phase 2
- Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric CancerCompletedNCT01345773
- Venous Thromboembolism Prophylaxis Post Cesarean SectionStatus unknownNCT01321788
- Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal SurgeryCompletedNCT01308528Phase 3
- Improving Venous Thromboembolism ProphylaxisCompletedNCT01304108Phase 4
- Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in SwitzerlandCompletedNCT01277536
- The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryCompletedNCT01267305Not applicable
- Graduated Compression Stockings (GCS) Pilot SubstudyCompletedNCT01234064Phase 3
- STA®-Liatest®D-Di-Exclusion of Venous ThromboembolismCompletedNCT01221805
- Prevention of Venous Thromboembolism Disease in Emergency DepartmentsCompletedNCT01212393
- Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thromboticsCompletedNCT01210755Phase 4
- Dose-confirmatory Bridging Study in Total Knee ReplacementCompletedNCT01206972Phase 3
- Dose-confirmatory Bridging Study in Total Hip ReplacementCompletedNCT01205932Phase 3
- Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous CatheterTerminatedNCT01195727Phase 1
- Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005CompletedNCT01176305